AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions.
第一作者:
Keisuke,Yasuda
第一单位:
The Institute for AIM Medicine, Tokyo, 162-8666, Japan; Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, 113-0033, Japan.
作者:
主题词
动物(Animals);人类(Humans);小鼠(Mice);凋亡调节蛋白质类(Apoptosis Regulatory Proteins);关节炎, 实验性(Arthritis, Experimental);关节炎, 类风湿(Arthritis, Rheumatoid);自身免疫疾病(Autoimmune Diseases);增生(Hyperplasia);炎症(Inflammation);受体, 清道夫(Receptors, Scavenger);滑膜(Synovial Membrane)
DOI
10.1016/j.jaut.2023.103149
PMID
38006711
发布时间
2024-05-06
- 浏览0
Journal of autoimmunity
103149页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文